| P2093 | author name string | Alberto Margonato | |
| | Gabriele Fragasso | |
| | Emanuela Setola | |
| | Lucilla Monti | |
| | Pier Marco Piatti | |
| | Giliola Calori | |
| | Altin Palloshi | |
| | Sergio Chierchia | |
| | Gianpietro Valsecchi | |
| | Guido Pozza | |
| | Chunzeng Lu | |
| P2860 | cites work | The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase | Q28373346 |
| | A novel potent vasoconstrictor peptide produced by vascular endothelial cells | Q29620540 |
| | Some biochemical aspects of the protective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation | Q34059096 |
| | Effect of trimetazidine on membrane damage induced by oxygen free radicals in human red cells | Q34446598 |
| | Paradoxical role of lipid metabolism in heart function and dysfunction | Q35655457 |
| | Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation | Q37372004 |
| | Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart | Q40304120 |
| | Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias | Q40619598 |
| | Metabolic management of ischaemic heart disease | Q40619954 |
| | Regulation of fatty acid oxidation in the mammalian heart in health and disease | Q40682538 |
| | Effects of trimetazidine on pHi regulation in the rat isolated ventricular myocyte | Q41932287 |
| | Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group | Q42138849 |
| | Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease | Q42538885 |
| | Fluorimetric methods for the measurement of intermediate metabolites (lactate, pyruvate, alanine, beta-hydroxybutyrate, glycerol) using a COBAS FARA centrifugal analyser | Q42785432 |
| | Effects of propranolol on the hemodynamic, coronary sinus blood flow and myocardial metabolic response to atrial pacing | Q44764738 |
| | Plasma lipolytic activity after subcutaneous administration of heparin and a low molecular weight heparin fragment | Q47194896 |
| | Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor | Q47295608 |
| | Plasma lipolytic activity and substrate oxidation after intravenous administration of heparin and a low molecular weight heparin fragment | Q47440477 |
| | Metabolism of exogenous substrates by coronary endothelial cells in culture. | Q50876916 |
| | Effects of low-dose heparin infusion on arterial endothelin-1 release in humans. | Q51578477 |
| | Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans. | Q51582709 |
| | Effects of ranolazine on ischemic threshold, coronary sinus blood flow, and myocardial metabolism in coronary artery disease | Q60302420 |
| | Internal pH, Na+, and Ca2+ regulation by trimetazidine during cardiac cell acidosis | Q67269624 |
| | Effects of excess free fatty acids on mechanical and metabolic function in normal and ischemic myocardium in swine | Q67376789 |
| | The relative contribution of glucose and fatty acids to ATP production in hearts reperfused following ischemia | Q67983961 |
| | Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia | Q68697945 |
| | Acute effects of trimetazidine evaluated by exercise testing | Q69468162 |
| | Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock | Q69509803 |
| | Comparison of trimetazidine with nifedipine in effort angina: a double-blind, crossover study | Q70284229 |
| | Effects of trimetazidine on ischemic contracture in isolated perfused rat hearts | Q71644831 |
| | Beta adrenergic blockade. Hemodynamics and myocardial energy metabolism in patients with ischemic heart disease | Q72107816 |
| | Increased in vivo expression and production of endothelin-1 by porcine cardiomyocytes subjected to ischemia | Q72187801 |
| | Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite | Q72199386 |
| | High-dose heparin decreases nitric oxide production by cultured bovine endothelial cells | Q73303028 |
| | Endothelin release: a marker for the severity of exercise-induced ischemia | Q73999661 |
| | Trimetazidine-induced enhancement of myocardial glucose utilization in normal and ischemic myocardial tissue: an evaluation by positron emission tomography | Q77298829 |
| | High-dose heparin impairs nitric oxide pathway and vasomotion in rats | Q77846334 |
| | Effects of trimetazidine on metabolic and functional recovery of postischemic rat hearts | Q78014325 |
| | ??? | Q63973657 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heparin | Q190016 |
| | coronary artery disease | Q844935 |
| P304 | page(s) | 413-419 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease: evaluation of the protective role of the metabolic modulator trimetazidine | |
| P478 | volume | 39 | |